Blue Water Vaccines Inc., an Ohio-based biopharmaceutical company focused on creating transformative vaccines solving global health challenges, has entered into an exclusive worldwide license agreement for the development of a Streptococcus Pneumoniae vaccine developed by a researcher at St. Jude Children’s Research Hospital. According to this announcement, acute otitis media caused by Streptococcus pneumoniae remains one of the most common infectious diseases worldwide despite widespread vaccination.
"2021 TVC National Summit"
- University of Tennessee, Knoxville
- Jun 02 2021
TAEBC "Advanced Energy Virtual Business Roundtable" - Middle Tennessee
- Jun 09 2021
"Made Here Market"
- The Biz Foundry, 114 North Cedar Avenue, Cookeville
- Jun 12 2021
TAEBC "Statewide Energy Incentives Webinar"
- Aug 03 2021
"GOVCON 2021" - TN Governor's Conference on Economic and Community Development
- Renaissance Nashville Hotel
- Aug 05 2021